PharmaResources (Shanghai) Co. Ltd. A Capital Reinvestment Ratio
PharmaResources (Shanghai) Co. Ltd. A capital reinvestment ratio. PharmaResources (Shanghai) Co. Ltd. A (301230) has a Capital Reinvestment Ratio of 0.32x as of December 2025, meaning it reinvests 0% of its operating cash flow (CN¥135.51 Million) in capital expenditures (CN¥43.32 Million). Check total reinvestment intensity of PharmaResources (Shanghai) Co. Ltd. A to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of PharmaResources (Shanghai) Co. Ltd. A (2020–2025)
Capital reinvestment ratio of PharmaResources (Shanghai) Co. Ltd. A from 2020 to 2025. This chart tracks PharmaResources (Shanghai) Co. Ltd. A's Capital Reinvestment Ratio across 6 annual periods. Also explore how fast is PharmaResources (Shanghai) Co. Ltd. A growing its equity to track the company's year-over-year net asset growth rate.
PharmaResources (Shanghai) Co. Ltd. A Capital Reinvestment Ratio by Year (2020–2025)
PharmaResources (Shanghai) Co. Ltd. A capital reinvestment ratio by year from 2020 to 2025. For the full cash flow conversion analysis, see PharmaResources (Shanghai) Co. Ltd. A (301230) cash conversion ratio.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.32x | CN¥135.51 Million | CN¥43.32 Million | ▼ -76.4% |
| 2024 | 1.35x | CN¥80.86 Million | CN¥109.40 Million | ▼ -88.6% |
| 2023 | 11.90x | CN¥20.86 Million | CN¥248.27 Million | ▲ +853.4% |
| 2022 | 1.25x | CN¥99.29 Million | CN¥123.97 Million | ▲ +42.5% |
| 2021 | 0.88x | CN¥105.12 Million | CN¥92.12 Million | ▲ +42.4% |
| 2020 | 0.62x | CN¥54.45 Million | CN¥33.51 Million | — |